| Literature DB >> 29449610 |
Daiani C Savi1,2, Khaled A Shaaban2,3, Francielly Maria Wilke Ramos Gos1, Larissa V Ponomareva2,3, Jon S Thorson2,3, Chirlei Glienke4, Jürgen Rohr5.
Abstract
Microorganisms associated with plants are highly diverse and can produce a large number of secondary metabolites, with antimicrobial, anti-parasitic and cytotoxic activities. We are particularly interested in exploring endophytes from medicinal plants found in the Pantanal, a unique and widely unexplored wetland in Brazil. In a bio-prospecting study, strains LGMF1213 and LGMF1215 were isolated as endophytes from Vochysia divergens, and by morphological and molecular phylogenetic analyses were characterized as Phaeophleospora vochysiae sp. nov. The chemical assessment of this species reveals three major compounds with high biological activity, cercoscosporin (1), isocercosporin (2) and the new compound 3-(sec-butyl)-6-ethyl-4,5-dihydroxy-2-methoxy-6-methylcyclohex-2-enone (3). Besides the isolation of P. vochysiae as endophyte, the production of cercosporin compounds suggest that under specific conditions this species causes leaf spots, and may turn into a pathogen, since leaf spots are commonly caused by species of Cercospora that produce related compounds. In addition, the new compound 3-(sec-butyl)-6-ethyl-4,5-dihydroxy-2-methoxy-6-methylcyclohex-2-enone showed considerable antimicrobial activity and low cytotoxicity, which needs further exploration.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29449610 PMCID: PMC5814415 DOI: 10.1038/s41598-018-21400-2
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Bayesian phylogenetic tree based on ITS sequence of rRNA gene of LGMF1215 and LGMF1213 and 15 described species of Phaeophleospora genus. Values on the node indicate Bayesian posterior probabilities. The species Botryosphaeria ribis was used as outgroup. Scale bar indicates the number of substitutions per site.
Figure 2Host and morphology of Phaeophleospora vochysiae LGMF1215 on Malt Extract Agar (MEA), Oatmeal Agar (OA) and Potato Dextrose Agar (PDA) at 28 °C after 14 days. (a) Vochysia divergens (b and c) Colony on MEA surface and reverse; (d and e) colony on OA surface and reverse; (f and g) colony on PDA surface and reverse.
Figure 3Macro- and micro-morphology of Phaeophleospora vochysiae LGMF1215. (a) Colony with pycnidium (arrow). (b and c) Mycelium consisting of septate, branched, verruculose hyphae in some points with red pigment inside. (d) Conidiophore and conidium. (e–g) Conidia. (h) Conidiophore.
Figure 4Chemical structures of compounds 1–3.
Physicochemical properties of compounds 1–3 isolated from cultivation of strain LGMF1215.
| (+)-Cercosporin (1) | (+)-Isocercosporin (2) | Compound 3 | |
|---|---|---|---|
| Molecular Formula | C29H26O10 | C29H26O10 | C14H24O4 |
| Appearance | Red solid, UV absorbing (254 nm) | Red solid, UV absorbing (254 nm) | Colorless oil, UV absorbing (254 nm) |
| 2 | Dark-green | Dark-green | |
| HPLC- | 21.45 (min) | 21.85 (min) | 18.19 (min) |
| (+) | 535 [M + H]+ | 535 [M + H]+ | 257 [M + H]+ |
| (+) | |||
| Found | 535.1598 [M + H]+ | 535.1599 [M + H]+ | 257.1748 [M + H]+ |
| Calcd. | 535.1599 for C29H27O10 [M + H]+ | 535.1599 for C29H27O10 [M + H]+ | 257.1747 for C14H25O4 [M + H]+ |
| (−) | |||
| Found | 533.1441 [M‒H]− | 533.1444 [M‒H]− | 255.1596 [M‒H]−, 291.1361 [M + Cl]− |
| Calcd. | 533.1453 for C29H25O10 [M‒H]− | 533.1453 for C29H25O10 [M‒H]− | 255.1601 for C14H23O4 [M‒H]− |
| UV/Vis λmax | 220, 270, 450, 470 (sh), 570 (sh) nm | 220, 270, 450, 470 (sh), 570 (sh) nm | 250 nm |
a)For HPLC, see Figs S4, S15 and S26.
13C (100 MHz) and 1H (400 MHz) NMR Spectroscopic Data of Compounds 1–3 in CDCl3 (δ in ppm) isolated from cultivation of strain LGMF1215, compared with the literature data.
| Position | (+)-Cercosporin ( | (+)-Isocercosporin ( | Data reported in literature for compound | Data reported in literature for compound | Position | Compound | |||
|---|---|---|---|---|---|---|---|---|---|
| 1,12 | 135.4, C | 136.8, C | 1 | 198.5, C | |||||
| 2, 11 | 153.0, C | 153.4, C | 2 | 148.1, C | |||||
| 3, 10 | 182.0, C | 181.9, C | 2-OCH3 | 59.7, CH3 | 3.62 (s) | ||||
| 3a, 9a | 108.4, C | 108.6, C | 3 | 144.7, C | |||||
| 3b, 9b | 128.1, C | 127.6, C | 4 | 68.8, CH | 4.56 (m) | ||||
| 4, 9 | 167.7, C | 167.8, C | 5 | 74.4, C | 3.87 (brd, 3.6) | ||||
| 4,9-OH | 14.81 (s) | 14.89 (s) | 14.86 (s) | 14.91 (s) | 6 | 50.4, C | |||
| 5, 8 | 109.5, CH | 7.06 (s) | 109.4, CH | 7.03 (s) | 7.07 (s) | 7.02 (s) | 6-CH3 | 18.9, CH3 | 1.08 (s) |
| 6, 7 | 163.6, C | 163.6, C | 7 | 25.4, CH2 | 1.81 (m), 1.73 (m) | ||||
| 6a, 6b | 113.1, C | 113.2, C | 8 | 7.7, CH3 | 0.86 (t, 7.6) | ||||
| 12a, 12b | 130.7, C | 131.8, C | 9 | 35.9, CH | 2.80 (m) | ||||
| 13, 16 | 42.4, CH2 | 3.57 (dd, 13.0, 7.1) | 42.5, CH2 | 3.49 (dd, 14.0, 3.2) | 3.59 (dd, 13.1, 7.0) | 3.51 (dd, 13.3, 3.4) | 9-CH3 | 18.1, CH3 | 1.19 (d, 6.9) |
| 14, 17 | 68.3, CH | 3.36 (m) | 69.8, CH | 3.68 (m) | 3.39 (m) | 3.70 (m) | 10 | 29.1, CH2 | 1.68 (m), 1.58 (m) |
| 15, 18 | 23.6, CH3 | 0.62 (d, 6.0) | 24.0, CH3 | 0.95 (d, 6.0) | 0.65 (d, 6.1) | 0.97 (d, 6.2) | 11 | 13.1, CH3 | 0.91 (t, 7.5) |
| 19, 21 | 61.4, CH3 | 4.19 (s) | 61.2, CH3 | 4.21 (s) | 4.21 (s) | 4.23 (s) | |||
| 20 | 92.8, CH2 | 5.72 (s) | 92.8, CH2 | 5.71 (s) | 5.75 (s) | 5.73 (s) | |||
δH (mult., J in [Hz]); Assignments supported by 2D HSQC and HMBC experiments.
Inhibition zones (in millimeters) of LGMF1215 crude extracts of different culture media and compounds 1~3 tested antibacterial and antifungal assays at 100 μg/disc.
| Extracts/compounds | Staphylococcus aureus | MRSA | Escherichia coli | Phyllosticta citricarpa | Colletotrichum abscissum |
|---|---|---|---|---|---|
| Extract produced using PD | 13 | 12 | 11 | 32 | 50 |
| Extract produced using Czapeck | — | — | — | 2 | 4 |
| Extract produced using MEA | 8 | — | 6 | 10 | 15 |
| Cercosporin | 46 | 45 | 28 | 30 | Ne |
| Isocercosporin | 35 | 27 | 20 | 28 | Ne |
| 3-(sec-butyl)-6-ethyl-4,5-dihydroxy-2-methoxy-6-methylcyclohex-2-enone | 14 | 14 | — | 30 | Ne |
| Control | 30 | 0 | 35 | 37 | 82 |
–denotes no measurable halo, antibacterial control: Ampicillin (1 mg/disc), Antifungal control: Derosal (1 mg/disc), ne: not evaluated.
Figure 5Dose-response viability assay of compounds 1–3 isolated from strain LGMF1215 against A549 (lung) and PC3 (prostate) human cancer cell lines for 72 hrs treatments. Note: each line represents a different treatment with a specific cell line and compound.